Frost & Sullivan

APRIL 21, 2021

2 – The consolidation of PPD with TMO’s Patheon manufacturing unit creates a compelling end-to-end offering for biopharma sponsors and an opportunity to cross-sell services through revenue stream synergies. TMO recorded the highest top-line Y-o-Y revenue growth of over 26% in 2020 in comparison to the last five years.

Biopharma 98

Biopharma Biotech Banking 98

Vantage Partners

JANUARY 19, 2024

It’s no great secret that M&A activity in bipoharma has been on the rise over the past 12 months. Analysis from EY found that life sciences M&A spend was up 34% last year relative to 2022, despite a reduction in deal volume.

Biopharma 83

Biopharma Life science Alliance partnership 83

Frost & Sullivan

AUGUST 9, 2021

Over the next two to three years, biopharma companies also will highly invest in DTx solutions, enabling the subsidized cost to patients in exchange for marketing and access to patient data.

Life science 98

Life science Biopharma Government Biopharmaceuticals 98

Frost & Sullivan

AUGUST 9, 2021

Over the next two to three years, biopharma companies also will highly invest in DTx solutions, enabling the subsidized cost to patients in exchange for marketing and access to patient data.

Life science 90

Life science Biopharma Government Biopharmaceuticals 90

Vantage Partners

NOVEMBER 17, 2020

As in the past, this conference featured insightful presentations from leaders across Biopharma alliance management. While we all wish we could be together in person, we wanted to extend kudos to the organizers at CHI for putting on an engaging and thought-provoking virtual event.

Alliance management 83

Alliance management Strategic alliances Biopharma Alliance partnership 83

ISTO / IEEE

JANUARY 12, 2022

A group of leading BioPharma companies, academic institutions, and non-profit data-sharing platforms have come together to establish the Clinical Research Data Sharing Alliance (CRDSA). PISCATAWAY, N.J., 12, 2022 (GLOBE NEWSWIRE) — Sharing clinical research data more widely has become a global priority.

Biopharma 113

Biopharma Legal Ecosystems Collaboration 113

Frost & Sullivan

JANUARY 28, 2021

Biopharma companies should partner with niche AI and data vendors to expedite drug design and development to reduce internal R&D risks for personalized therapies. Enable screening, diagnoses and the fulfillment of treatments through existing innovation in smart devices , mHealth wearables, apps, and diagnostics.

Biopharma 98

Biopharma Ecosystems Government 98

Jake Jorgovan

NOVEMBER 15, 2023

Industries: Artificial Intelligence, Cloud Computing, Cybersecurity, Data Science, E-Commerce, Green Tech, Identity & Access Management, Internet of Things, Machine Learning, SoftwareBiotech, Biopharma, Computational Biology, Diagnostics, Genomics, Healthcare, Health Insurance, Medical Devices, Pharmaceuticals, TherapeuticsBanking, Blockchain, (..)

Life science 130

Life science Fintech Telecommunications Biopharma 130

Frost & Sullivan

MAY 23, 2023

BrightInsight partners with biopharma and medtech companies to rapidly build, maintain, and scale compliant companion apps, Software as a Medical Device (SaMD) solutions, algorithms, and analytics dashboards that aim to improve clinical outcomes and enhance the patient journey.

Biopharma 52

Biopharma Life science 52

Jake Jorgovan

APRIL 4, 2024

Their client base includes global top 10 pharma companies, leading medical device pioneers, emerging biopharmas & biotechs, multinational contract & clinical research organizations, global consumer health brands, and specialist suppliers and consultancies.

Biotechnology 130

Biotechnology Life science Biotech Biopharma 130

Frost & Sullivan

AUGUST 29, 2024

However, the pharma/biopharma industry overall shows stagnant R&D activity. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%. As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8%

Biopharma 52

Biopharma Biotechnology Contract research organization Utilities 52

Frost & Sullivan

MARCH 22, 2024

However, the pharma/biopharma industry shows overall stagnant R&D activity. Small-to-mid and emerging biopharma players contribute over 16%. As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% increase from 2022. billion, with a modest 2.5%

Ecosystems 52

Ecosystems Biopharma Biotech Contract research organization 52

LaVoie Health Science Blog

FEBRUARY 7, 2024

LaVoie , President and Chief Executive Officer of LaVoieHealthScience said, “Katie brings an entrepreneurial mindset to our agency and a record of accomplishment of client success across a portfolio pharmaceutical, biopharma, life science, medical technology, and related fields.

Biopharma 52

Biopharma Life science 52

LaVoie Health Science Blog

AUGUST 16, 2022

Plumstead brings expertise in commercial strategic communications programming and execution from pharma to biopharma and beyond. She has worked across a range of medical and therapeutic areas, including oncology, ophthalmology, rare disease, neuroscience, rheumatology, infectious diseases, and women’s health. Prior to joining LHS, Ms.

Biopharma 52

Biopharma Biotechnology 52

BTD Consulting

APRIL 11, 2022

ASAP global, corporate, and individual members represent a wide variety of industries that include high tech, biopharma, life science, finance, fintech, insurance, energy, consulting, and many others. ASAP is also the only association that awards CA-AM and CSAP certification to qualified alliance professionals.

Channels and alliances 52

Channels and alliances Biopharma Strategic alliances Alliance management 52

Jake Jorgovan

NOVEMBER 27, 2023

Biopharmaceutical Consulting: Supporting every aspect of the biopharma value chain, including R&D, operations, manufacturing, commercialization, and mergers and acquisitions (M&A).

Life science 130

Life science Biopharmaceuticals Biotech Mergers and acquisition activities 130

Frost & Sullivan

AUGUST 23, 2023

The combination of claims and EHR data, an expanding incorporation of genomic insights, and a continued emphasis on RWE and diversity, make Optum the partner of choice for biopharmaceutical (biopharma) companies seeking to create higher-value treatments while accelerating their time to market.

Life science 52

Life science Biopharmaceuticals Biopharma Partnering capability and readiness 52

Frost & Sullivan

AUGUST 11, 2021

Cardinal Health Specialty Solutions is a leading provider of technology and distribution solutions to specialty healthcare practices and biopharma manufacturers. About Cardinal Health Specialty Solutions.

Biopharma 52

Biopharma Life science Government 52

Frost & Sullivan

MAY 3, 2023

The company stands out in the industry as it works hard to deliver high-quality scientific services while identifying solutions for big biopharma. George Clinical upholds its agility and responsiveness towards clients with nearly 500 employees, making it more flexible, adaptable, and faster than competitors with more employees.

Contract research organization 52

Contract research organization Biopharmaceuticals Biopharma Business development 52

Frost & Sullivan

DECEMBER 13, 2022

With a strong customer-centric approach, the company secures its position as a trusted partner, especially amongst small to mid-tier pharma and biopharma players,” added Natalia Casanovas, a Frost & Sullivan Best Practices Research Analyst.

Biopharma 52

Biopharma Biotech Engineering Collaboration 52

Frost & Sullivan

APRIL 3, 2024

Simtra BioPharma Solutions announced over $250 million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana. SCHOTT Pharma announced expansion plans in the US to meet the growing demand for mRNA vaccines, GLP1 drugs, and biologics.

Biopharmaceuticals 59

Biopharmaceuticals Biopharma Biotechnology Life science 59

Frost & Sullivan

APRIL 25, 2023

years, to become a truly global company with a diverse mix of public sector and biopharma clients. Christine Dingivan said, “This award recognizes the efforts of everyone who works at Emmes. It reflects a successful transition, in only 2.5

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52

LaVoie Health Science Blog

APRIL 13, 2023

We recognize the need to provide a unique set of services to companies focused on the future of biopharma and medtech that are right sized to fit these companies’ unique communications needs in the current market,” said Donna L. LaVoie , President and CEO of LaVoieHealthScience.

Biopharma 52

Biopharma Business development 52

Frost & Sullivan

DECEMBER 8, 2022

TrialWireä is HIPAA compliant and uses the most advanced technologies to solve the patient recruitment crisis for biopharma. Sponsors and CROs have real-time de-identified views of study recruitment progress.

Biotech 52

Biotech Life science Biopharma 52

Frost & Sullivan

JUNE 24, 2024

Antibody-Drug Conjugate (ADC) Targets: Current and Future Targets Remains a Priority Focus Big biopharma has embraced the trend of transitioning primary cancer treatment from chemotherapy to innovative targeted treatments since the ADC market is projected to grow at a CAGR of 25.4%

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Collaboration Ecosystems 52

LaVoie Health Science Blog

SEPTEMBER 22, 2022

The late Summer and early Fall have been busy with the very well-attended 42nd Canaccord Genuity Growth Conference in August, along with Citi’s 19th Annual BioPharma and Wells Fargo’s 2022 Healthcare Conferences in early September. The return of in-person conferences coming back to Boston is great to see.

Biopharma 52

Biopharma Collaboration 52

BTD Consulting

APRIL 11, 2022

ASAP global, corporate, and individual members represent a wide variety of industries that include high tech, biopharma, life science, finance, fintech, insurance, energy, consulting, and many others. ASAP is also the only association that awards CA-AM and CSAP certification to qualified alliance professionals.

Channels and alliances 40

Channels and alliances Biopharma Strategic alliances Alliance management 40

Frost & Sullivan

JUNE 26, 2024

The convergence of biopharma, digital therapeutics, medical devices, and health technology is enhancing patient care, improving outcomes, and reducing costs. Combining digital therapeutics, artificial intelligence (AI)-based diagnostics, and behavioral therapies with traditional treatments is crucial for managing cardiometabolic diseases.

Biopharma 40

Biopharma Life science Strategic partnership Ecosystems 40

LaVoie Health Science Blog

JULY 1, 2020

Given the number of public companies – including many blue-chip pharma and biopharma large caps – that have seen their stock prices swing wildly, from this strict valuation perspective alone, the current environment seems as if it should present a historic opportunity to activist investors.

Life science 52

Life science Biotech Biopharma Value creation 52

Frost & Sullivan

JULY 22, 2021

RNA therapeutics investment has a better chance of commercial success and enables better returns in less time for market participants, finds Frost & Sullivan. Santa Clara, Calif.

Biotech 98

Biotech Biopharmaceuticals Biotechnology Government 98

Jake Jorgovan

MAY 20, 2024

BCG Biopharma : BCG Biopharma helps companies innovate and bring new medicines to market quickly by utilizing digital tools, data, and advanced analytics across R&D, commercial models, operations, and corporate finance. They focus on integrating digital tools and data analytics to streamline processes and foster sustainable growth.

Biopharma 130

Biopharma Biotech Life science Partnering capability and readiness 130

Frost & Sullivan

MAY 12, 2021

Technology, industry collaborations and a desire to innovate will help participants sustain their growth momentum and achieve manufacturing scale, finds Frost & Sullivan. SANTA CLARA, Calif. – May 12, 2021 – The biopharmaceutical industry is facing its biggest test in recent times.

Biopharmaceuticals 52

Biopharmaceuticals Life science Construction Government 52

Jake Jorgovan

JUNE 3, 2024

Boston Consulting Group (BCG) Boston Consulting Group (BCG) provides strategic consulting services to biopharma companies, helping them leverage new technologies, digital transformation, and advanced analytics to accelerate innovation and bring new medicines to market more efficiently.

Biopharma 130

Biopharma Biotech Biopharmaceuticals Life science 130

Jake Jorgovan

FEBRUARY 1, 2024

Why work with Eradigm Consulting: Eradigm Consulting's approach is driven by a passion for high performance and delivering excellence in the biopharma industry. Focus on emerging trends such as digital innovation and the evolving market in China.

Life science 130

Life science Biotech Biotechnology Engineering 130

Jake Jorgovan

APRIL 25, 2024

Since its establishment, Proclinical Executive has focused exclusively on the life sciences sector, including biopharma, medical devices, and digital health. The firm is dedicated to securing senior leadership and C-suite positions, leveraging a deep understanding of the life sciences industry to match companies with top executive talent.

Life science 130

Life science Biotechnology Biotech Partnering capability and readiness 130

LaVoie Health Science Blog

JULY 16, 2021

What are some of the unique considerations that biopharma and life science firms must consider in mapping out their ESG strategies? Certainly few industries have received more scrutiny over the past year than biopharma. Enough said.

Life science 69

Life science Biopharma Biotech Biotechnology 69

LaVoie Health Science Blog

JANUARY 26, 2021

Panelists, including myself as moderator, consisted of industry leaders, including Dr. Alexandra Goll, Managing Director of Biopharma Advisory; Brad Loncar, CEO of Loncar Investments; and Amit Munshi, President, CEO and Board Member of Arena Pharmaceuticals.

Biopharma 52

Biopharma Life science Biotechnology 52